向患者为中心的药物批准,用于治疗罕见疾病
1Department of Economics and Institute for Policy Research, Northwestern University, Evanston, IL, USA.
概括
这项研究建议用统计决策理论替代假设测试,以获得药物批准. 这一变化将通过减少样本大小要求而改善治疗罕见疾病的药物开发,而不会影响试验数据.
科学领域:
- 生物统计学 生物统计学
- 药物开发 药物开发
- 监管科学 监管科学
背景情况:
- 目前的药物批准过程,特别是对于罕见疾病,在假设测试方面面临挑战.
- 假设测试中的不对称错误概率可能会对新药批准产生偏见.
- 药物批准的统计能力要求阻碍了罕见病药物开发,原因是患者人数较少.
研究的目的:
- 提出设计和分析罕见病药物批准临床试验的改进方法.
- 解决药物批准过程中假设测试的局限性.
- 加强用于治疗罕见疾病的药物的评估.
主要方法:
- 在监管药物批准中对假设测试的方法分析.
- 假设测试与临床试验评估的统计决策理论的比较.
- 专注于优化样本大小和决策标准.
主要成果:
- 药物批准中的假设测试被认为是有害的,对新药产生偏见.
- 统计能力要求对罕见疾病药物开发构成重大障碍.
- 统计决策理论为假设测试提供了一个优越的替代方案.
结论:
- 采用统计决策理论将克服当前药物批准方法的缺陷.
- 接近最佳性可以指导样本大小的确定,减少对罕见疾病试验的要求.
- 这种方法提高了临床试验的信息性,同时允许较小的样本大小用于罕见病药物评估.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
725
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
725
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Drug Administration and Therapy Phases: Overview
457
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
457


